- Home
- ATRA vs BEAT Comparison
ATRA vs BEAT Comparison
Compare ATRA & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATRA | BEAT |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | United States | United States |
| Employees | N/A | 16 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9M | 44.8M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATRA | BEAT |
|---|---|---|
| Price | $4.83 | $0.84 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $5.00 | ★ $5.63 |
| AVG Volume (30 Days) | 58.9K | ★ 1.4M |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 122.52 | N/A |
| EPS | ★ 2.57 | N/A |
| Revenue | ★ $120,772,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $315.97 |
| P/E Ratio | $1.91 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.92 | $0.54 |
| 52 Week High | $19.15 | $4.00 |
Technical Indicators
Market Signals| Indicator | ATRA | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 46.60 | 35.22 |
| Support Level | $4.70 | $0.80 |
| Resistance Level | $5.47 | $1.28 |
| Average True Range (ATR) | 0.31 | 0.07 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 30.67 | 22.35 |
Price Performance
Historical ComparisonAbout ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.